POTC Subscribers Took Profits in OREX this AM and are Moving On ..

We are very proud OREX's drug Contrave received a favorable ruling from an FDA advisory panel, and more happy for POTC subscribers who booked astronomical profits in the JAN $6 CALLs on open.
 
We're now shifting our focus to two other possible biotech winners. The two stocks and option trade advice is as follows ...
 
To receive this information, please sign-up through PayPal in the right margin and begin the New Year on an exciting journey of aggressive yet more patient and scientific trading strategies.
 
The Psychology of the Call team thanks all who signed up to our services in 2010, without your support we would not exist.